Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

Hemophagocytic lymphohistocytosis (HLH) is characterized by fulminant cytokine storm
leading to multiple organ dysfunction and high mortality. HLH is classified into familial (fHLH) …

Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction …

Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …

The pandemic 2019 novel coronavirus disease (COVID-19) shares certain clinical
characteristics with other acute viral infections. We studied the whole-blood transcriptomic host …

Background Since the Sepsis-3 criteria, change in Sequential Organ Failure Assessment (SOFA)
score has become a key component of sepsis identification. Thus, it could be argued …

Background Clarithromycin may act as immune-regulating treatment in sepsis and acute
respiratory dysfunction syndrome. However, clinical evidence remains inconclusive. We aimed …

Severe alcoholic hepatitis (sAH), defined by a modified discriminant function≥ 32, is the
most severe form of alcohol-induced liver disease and is associated with a 1-month mortality …

Background: Macrophage activation-like syndrome (MALS) and complex immune
dysregulation (CID) often underlie acute respiratory distress (ARDS) in COVID-19. We aimed to …

Acute respiratory distress syndrome (ARDS) in COVID-19 has been associated with
catastrophic inflammation. We present measurements in humans and a new animal model …